litlas
Log inCreate account

Suzanne George

Active 1995–2025

131
Papers
18,631
Citations
74
h-index
126
i10-index

Citations

Citations per year for Suzanne George1992: 1 citations1996: 2 citations1997: 2 citations1998: 6 citations1999: 9 citations2000: 8 citations2001: 5 citations2002: 5 citations2003: 5 citations2004: 4 citations2005: 11 citations2006: 11 citations2007: 76 citations2008: 80 citations2009: 149 citations2010: 123 citations2011: 103 citations2012: 109 citations2013: 118 citations2014: 122 citations2015: 111 citations2016: 116 citations2017: 137 citations2018: 108 citations2019: 536 citations2020: 542 citations2021: 632 citations2022: 546 citations2023: 398 citations2024: 605 citations2025: 223 citations2026: 4 citations1993–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,717 citing papers, 27.7% of this breakdownChina: 548 citing papers, 8.8% of this breakdownItaly: 424 citing papers, 6.8% of this breakdownFrance: 362 citing papers, 5.8% of this breakdownUnited Kingdom: 352 citing papers, 5.7% of this breakdownGermany: 299 citing papers, 4.8% of this breakdownNetherlands: 235 citing papers, 3.8% of this breakdownCanada: 231 citing papers, 3.7% of this breakdownSpain: 200 citing papers, 3.2% of this breakdownJapan: 187 citing papers, 3% of this breakdownAustralia: 138 citing papers, 2.2% of this breakdownBelgium: 122 citing papers, 2% of this breakdown
0%27.7%Other 22.5%

Institutions

Fields

  • Medicine79.9%
  • Biochemistry, Genetics and Molecular Biology14%
  • Immunology and Microbiology3.1%
  • Engineering0.5%
  • Chemistry0.3%
  • Computer Science0.3%
  • Other1.9%

Topics

  • Sarcoma Diagnosis and Treatment8.7%
  • Gastrointestinal Tumor Research and Treatment5.2%
  • Endometrial and Cervical Cancer Treatments3.3%
  • Cancer Immunotherapy and Biomarkers2.9%
  • Chemotherapy-induced cardiotoxicity and mitigation2.2%
  • Uterine Myomas and Treatments2.2%
  • Other75.5%

Coauthors

All papers

Open in search
  1. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

    Authors: George D. Demetri, Allan T. van Oosterom, Christopher R. Garrett, Martin E. Blackstein, Manisha H. Shah, Jaap Verweij, Grant A. McArthur, Ian Judson, Michael C. Heinrich, Jeffrey A. Morgan, Jayesh Desai, Christopher D.�M. Fletcher, Suzanne George, Carlo L. Bello, Xin Huang, Charles M. Baum, Paolo G. Casali - The Lancet 2006 cited by 2,595

  2. Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

    Authors: Silvia Stacchiotti, Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée, Dario Callegaro, Paolo G. Casali, RuRu Chun-Ju Chiang, George D. Demetri, Elisabeth G. Demicco, Jayesh Desai, Mikael Eriksson, Hans Gelderblom, Suzanne George, Mrinal M. Gounder, Alessandro Gronchi, Abha A. Gupta, Rick L. Haas, Andrea Hayes‐Jardon, Peter Hohenberger, Kevin B. Jones, Robin L. Jones, Bernd Kasper, Akira Kawai, David G. Kirsch, Eugene S. Kleinerman, Axel Le Cesne, Jiwon Lim, María Dolores Chirlaque López, Roberta Maestro, Rafael Marcos‐Gragera, Javier Martín‐Broto, Tomohiro Matsuda, Olivier Mir, Shreyaskumar Patel, Chandrajit P. Raut, Albiruni R. Abdul Razak, Damon R. Reed, Piotr Rutkowski, Roberta Sanfilippo, Marta Sbaraglia, Inga‐Marie Schaefer, D. Strauß, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Winette T.A. van der Graaf, Winan J. van Houdt, Otto Visser, Margaret von Mehren, Andrew J. Wagner, Breelyn A. Wilky, Young‐Joo Won, Christopher D.�M. Fletcher, Angelo Paolo Dei Tos, Annalisa Trama - Cancer 2021 cited by 227

  3. Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma

    Authors: Suzanne George, Diana Miao, George D. Demetri, Dennis O. Adeegbe, Scott J. Rodig, Sachet A. Shukla, Mikel Lipschitz, Ali Amin‐Mansour, Chandrajit P. Raut, Scott L. Carter, Peter S. Hammerman, Gordon J. Freeman, Catherine J. Wu, Patrick A. Ott, Kwok‐Kin Wong, Eliezer M. Van Allen - Immunity 2017 cited by 485

  4. Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial

    Authors: Michael C. Heinrich, Robin L. Jones, Margaret von Mehren, Patrick Schöffski, César Serrano, Yoon‐Koo Kang, Philippe A. Cassier, Olivier Mir, Ferry A.L.M. Eskens, William D. Tap, Piotr Rutkowski, Sant P. Chawla, Jonathan C. Trent, Meera Tugnait, Erica N Evans, Tamieka Lauz, Teresa Zhou, Maria Roche, Beni B. Wolf, Sebastian Bauer, Suzanne George - The Lancet Oncology 2020 cited by 304

  5. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

    Authors: Jean‐Yves Blay, César Serrano, Michael C. Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz‐Soto, Suzanne George, Margaret von Mehren - The Lancet Oncology 2020 cited by 407

  6. Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO–Friends of Cancer Research Joint Research Statement

    Authors: Edward S. Kim, Thomas S. Uldrick, Caroline Schenkel, Suanna S. Bruinooge, R. Donald Harvey, Allison Magnuson, Alexander I. Spira, James L. Wade, Mark Stewart, Diana Merino Vega, Julia A. Beaver, Andrea Denicoff, Gwynn Ison, S. Percy Ivy, Suzanne George, Raymond P. Perez, Patricia A. Spears, William D. Tap, Richard L. Schilsky - Clinical Cancer Research 2021 cited by 111

  7. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

    Authors: Tammy F. Chu, Maria A. Rupnick, Risto Kerkelä, Susan M. Dallabrida, David Zurakowski, Lisa Nguyen, Kathleen C. Woulfe, Elke Pravda, Flávia Cassiola, Jayesh Desai, Suzanne George, David M. Harris, Nesreen S. Ismail, Jey-Hsin Chen, Frederick J. Schöen, Annick D. Van den Abbeele, George D. Demetri, Thomas Force, Ming Hui Chen, Jeffrey A. Morgan - The Lancet 2007 cited by 1,073

  8. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

    Authors: Margaret von Mehren, R. Lor Randall, Robert S. Benjamin, Sarah G Boles, Marilyn M. Bui, Kristen N. Ganjoo, Suzanne George, Ricardo J. Gonzalez, Martin J. Heslin, John M. Kane, Vicki L. Keedy, Edward Kim, Henry Koon, Joel L. Mayerson, Martin McCarter, Sean V. McGarry, Christian Meyer, Zachary S. Morris, Richard J. O’Donnell, Alberto S. Pappo, I. Benjamin Paz, Ivy A. Petersen, John D. Pfeifer, Richard F. Riedel, Bernice Ruo, Scott M. Schuetze, William D. Tap, Jeffrey D. Wayne, Mary Anne Bergman, Jillian L. Scavone - Journal of the National Comprehensive Cancer Network 2018 cited by 733

  9. Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial

    Authors: Sebastian Bauer, Robin L. Jones, Jean‐Yves Blay, Hans Gelderblom, Suzanne George, Patrick Schöffski, Margaret von Mehren, John Zalcberg, Yoon‐Koo Kang, Albiruni Abdul Razak, Jonathan C. Trent, Steven Attia, Axel Le Cesne, Ying Su, Julie Meade, Tao Wang, Matthew L. Sherman, Rodrigo Ruiz‐Soto, Michael C. Heinrich - Journal of Clinical Oncology 2022 cited by 111

  10. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology

    Authors: Wui-Jin Koh, Nadeem R. Abu‐Rustum, Sarah Bean, Kristin Bradley, Susana M. Campos, Kathleen R. Cho, Hye Sook Chon, Christina Chu, David E. Cohn, Marta A. Crispens, Shari Damast, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter J. Frederick, David K. Gaffney, Suzanne George, Ernest Han, Susan A. Higgins, Warner K. Huh, John R. Lurain, Andrea Mariani, David G. Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda N. Fader, Steven W. Remmenga, R. Kevin Reynolds, T. Tillmanns, Stefanie Ueda, Emily Wyse, Catheryn M. Yashar, Nicole R. McMillian, Jillian L. Scavone - Journal of the National Comprehensive Cancer Network 2018 cited by 657

  11. Molecular Subtypes ofKIT/PDGFRAWild-Type Gastrointestinal Stromal Tumors

    Authors: Sosipatros A. Boikos, Alberto S. Pappo, J. Keith Killian, Michael P. LaQuaglia, Chris B. Weldon, Suzanne George, Jonathan C. Trent, Margaret von Mehren, Jennifer Wright, J. D. Schiffman, Margarita Raygada, Karel Pacák, Paul S. Meltzer, Markku Miettinen, Constantine A. Stratakis, Katherine A. Janeway, Lee J. Helman - JAMA Oncology 2016 cited by 407

  12. Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study

    Authors: Eytan Ben‐Ami, Constance M. Barysauskas, Sarah Solomon, Kadija Tahlil, Rita Malley, Melissa Hohos, Kathleen Polson, Margaret Loucks, Mariano Severgnini, Tara Patel, Amy Cunningham, Scott J. Rodig, F. Stephen Hodi, Jeffrey A. Morgan, Priscilla Merriam, Andrew J. Wagner, Geoffrey I. Shapiro, Suzanne George - Cancer 2017 cited by 223

  13. Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

    Authors: César Serrano, Adrián Mariño‐Enríquez, Derrick L. Tao, Julia Ketzer, Grant Eilers, Mei‐Jun Zhu, Channing Yu, Aristotle M. Mannan, Brian P. Rubin, George D. Demetri, Chandrajit P. Raut, Ajia Presnell, Arin McKinley, Michael C. Heinrich, Jeffrey T. Czaplinski, Ewa Sicińska, Sebastian Bauer, Suzanne George, Jonathan A. Fletcher - British Journal of Cancer 2019 cited by 166

  14. National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

    Authors: Funda Meric‐Bernstam, James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin, Roisin E. O’Cearbhaill, Suzanne George, Julia Glade Bender, Gary H. Lyman, James V. Tricoli, David R. Patton, Stanley R. Hamilton, Robert J. Gray, Douglas S. Hawkins, Bhanumati Ramineni, Keith T. Flaherty, Petros Grivas, Timothy A. Yap, Jordan Berlin, James H. Doroshow, Lyndsay N. Harris, Jeffrey A. Moscow - Clinical Cancer Research 2023 cited by 59

  15. NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021

    Authors: Margaret von Mehren, John M. Kane, Marilyn M. Bui, Edwin Choy, Mary Connelly, Sarah Dry, Kristen N. Ganjoo, Suzanne George, Ricardo González, Martin J. Heslin, Jade Homsi, Vicki L. Keedy, Ciara M. Kelly, Edward Kim, David A. Liebner, Martin D. McCarter, Sean V. McGarry, Christian F. Meyer, Alberto S. Pappo, Amanda Parkes, I. Benjamin Paz, Ivy A. Petersen, Matthew M. Poppe, Richard F. Riedel, Brian P. Rubin, Scott M. Schuetze, Jacob E. Shabason, Jason K. Sicklick, Matthew B. Spraker, Melissa N. Zimel, Mary Anne Bergman, Giby V. George - Journal of the National Comprehensive Cancer Network 2020 cited by 303

  16. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

    Authors: George D. Demetri, Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón, Angelo Paolo Dei Tos, Jayesh Desai, Jonathan A. Fletcher, Hans Gelderblom, Suzanne George, Alessandro Gronchi, Rick L. Haas, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Ian Judson, Y-K Kang, Akira Kawai, Alexander J. Lazar, Axel Le Cesne, Roberta Maestro, Robert G. Maki, Javier Martín‐Broto, Shreyaskumar Patel, Frédérique Penault‐Llorca, Chandrajit P. Raut, Piotr Rutkowski, Akmal Safwat, Marta Sbaraglia, Inga‐Marie Schaefer, Lin Shen, César Serrano, P. Schöffski, Silvia Stacchiotti, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Jonathan C. Trent, Claudia Valverde, Winette T.A. van der Graaf, M. von Mehren, Andrew J. Wagner, E. Wardelmann, Yoichi Naito, John Zalcberg, Jean‐Yves Blay - Annals of Oncology 2020 cited by 145

  17. Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study

    Authors: Yoon‐Koo Kang, Suzanne George, Robin L. Jones, Piotr Rutkowski, Lin Shen, Olivier Mir, Shreyaskumar Patel, Yongjian Zhou, Margaret von Mehren, Peter Hohenberger, Víctor M. Villalobos, Mehdi Brahmi, William D. Tap, Jonathan C. Trent, Maria A. Pantaleo, Patrick Schöffski, Kevin He, Paggy Hew, Kate J. Newberry, Maria Roche, Michael C. Heinrich, Sebastian Bauer - Journal of Clinical Oncology 2021 cited by 116

  18. Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody–Drug Conjugate

    Authors: Kenji Iida, Amr H. Abdelhamid Ahmed, Akiko Kawano Nagatsuma, Tomoko Shibutani, Satoru Yasuda, Michiko Kitamura, Chiharu Hattori, Manabu Abe, Jun Hasegawa, Takuma Iguchi, Tsuyoshi Karibe, Takashi Nakada, Koichiro Inaki, Reiko Kamei, Yuki Abe, Taisei Nomura, Jessica L. Andersen, Sandro Santagata, Matthew L. Hemming, Suzanne George, Toshihiko Doi, Atsushi Ochiai, George D. Demetri, Toshinori Agatsuma - Cancer Discovery 2021 cited by 50

  19. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021

    Authors: Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Kristin Bradley, Susana M. Campos, Junzo Chino, Hye Sook Chon, Christina Chu, David E. Cohn, Marta A. Crispens, Shari Damast, Elisabeth Diver, Christine M. Fisher, Peter J. Frederick, David K. Gaffney, Suzanne George, Robert Giuntoli, Ernest Han, Brooke E. Howitt, Warner K. Huh, Jayanthi Lea, Andrea Mariani, David G. Mutch, Larissa Nekhlyudov, Mirna Podoll, Steven W. Remmenga, R. Kevin Reynolds, Ritu Salani, Rachel Sisodia, Pamela T. Soliman, Edward J. Tanner, Stefanie Ueda, Renata R. Urban, Stephanie L. Wethington, Emily Wyse, Kristine Zanotti, Nicole R. McMillian, Angela D. Motter - Journal of the National Comprehensive Cancer Network 2021 cited by 173

  20. Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial

    Authors: Robin L. Jones, César Serrano, Margaret von Mehren, Suzanne George, Michael C. Heinrich, Yoon‐Koo Kang, Patrick Schöffski, Philippe A. Cassier, Olivier Mir, Sant P. Chawla, Ferry A.L.M. Eskens, Piotr Rutkowski, William D. Tap, Teresa Zhou, Maria Roche, Sebastian Bauer - European Journal of Cancer 2021 cited by 136

  21. Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial

    Authors: Michael C. Heinrich, Robin L. Jones, Suzanne George, Hans Gelderblom, Patrick Schöffski, Margaret von Mehren, John Zalcberg, Yoon‐Koo Kang, Albiruni Abdul Razak, Jonathan C. Trent, Steven Attia, Axel Le Cesne, Brittany L. Siontis, David Goldstein, Kjetil Boye, César Sánchez, Neeltje Steeghs, Piotr Rutkowski, Mihaela Druta, César Serrano, Neeta Somaiah, Ping Chi, William M. Reichmann, Kam Sprott, Haroun Achour, Matthew L. Sherman, Rodrigo Ruiz‐Soto, Jean‐Yves Blay, Sebastian Bauer - Nature Medicine 2024 cited by 52

  22. Soft Tissue and Uterine Leiomyosarcoma

    Authors: Suzanne George, César Serrano, Martee L. Hensley, Isabelle Ray‐Coquard - Journal of Clinical Oncology 2017 cited by 241

  23. A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results

    Authors: Steven Attia, Vanessa Bolejack, Kristen N. Ganjoo, Suzanne George, Mark Agulnik, Daniel A. Rushing, Elizabeth T. Loggers, Michael B. Livingston, Jennifer Wright, Sant P. Chawla, Scott H. Okuno, Denise K. Reinke, Richard F. Riedel, Lara E. Davis, Christopher W. Ryan, Robert G. Maki - Cancer Medicine 2022 cited by 56

  24. Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)

    Authors: Matthew Ingham, Jacob B. Allred, Li Chen, Biswasjit Das, Bose Kochupurakkal, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess, ­Mahesh Seetharam, Sosipatros A. Boikos, Nam Q. Bui, James L. Chen, Julia Close, Gregory M. Coté, Premal H. Thaker, S. Percy Ivy, Sminu Bose, Alan D. D’Andrea, Adrián Mariño‐Enríquez, Geoffrey I. Shapiro, Gary K. Schwartz - Journal of Clinical Oncology 2023 cited by 46